ARS Pharmaceuticals, Inc

Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. We are developing a product that patients and their caregivers can use without anxiety or hesitation, confident in the effectiveness of the both product and the ability to administer it. We are developing ARS-1, a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient and more reliable for patients and loved ones at-risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis

Ars pharmaceuticals, inc operates in the Pharmaceutical manufacturing industry.

Ars pharmaceuticals, inc's revenue is 1m - 10m

Ars pharmaceuticals, inc has 51 - 200 employees.